Hindman Andrew A. - Insider Stock Trading - OpenInsider

CIK: 1607965 - Address: C/o Theravance Biopharma Us, Inc., 901 Gateway Blvd, South San Francisco, CA 94080

9 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	4	2	3	4	6	-7	-28	-3
S	%wins				0	25	50	50	67	100	49

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/22/22 16:07	11/18/22	TBPH	Theravance Biopharma, Inc.	E9	Health	Drug	Pharmaceutical Preparations	Hindman Andrew A.	CA	O	SVP,CFO	S	-716	11.02	0	-65	-14	385	D
12/6/18 08:05	12/3/18	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-15	20.56	0	-1	-13	5	D
5/30/18 07:51	5/25/18	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-1,034	24.26	0	-43	-90	5	D
12/5/17 07:40	12/1/17	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-17	20.54	0	-1	-2	45	D
5/17/17 15:57	5/15/17	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-121	15.75	14	-8	-14	46	D	-47	-40	-21	-37	-25	-2	-2	-2
12/5/16 17:09	12/1/16	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-9	20.72	12	0	-1	49	D	-45	-45	-32	-16	1	-2	-2	-2	2	1	-3	30
5/16/16 15:12	5/13/16	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-127	26.11	13	-5	-9	50	D	-12	-12	-29	-21	1	-12	4	-3	2	0	-2	-8	-22
12/3/15 16:39	12/1/15	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S	-17	38.26	18	0	-1	55	D	11	2	23	15	18	1	0	-2	3	2	15	-2	-21	-44
5/15/15 17:38	5/13/15	ACOR	Acorda Therapeutics Inc		Health	BioPrd	Biological Products, (No Diag	Hindman Andrew A.	NY	O	Chief Bu	S.m	-142	29.82	21	-5	-8	55	D	-12	-1	-17	-18	-11	-10	3	-1	2	7	7	5	23	-12

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact